Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized COVID-19 Patients Infected With Pre-Omicron Variants.
Simone BerettaViviana CristilloGiorgia CameraCarlo Morotti ColleoniGaia PellitteriBeatrice VitiElisa BianchiStefano GipponiMaria GrimoldiMariarosaria ValenteSusanna GuttmannMaria Sofia CotelliPasquale PalumboGiorgio GelosaStefano MelettiCristina SchenoneDonatella OttavianiMassimo FilippiAndrea ZiniPaola BasilicoLucia TancrediPietro CortelliMassimiliano BragaValeria De GiuliSerenella ServideiDamiano PaolicelliFederico VerdeStefano CaproniAntonio PisaniVincenzina Lo ReLuca MassacesiDaria Valeria RoccatagliataPaolo ManganottiDaniele L A SpitaleriAnna FormentiMarta PiccoliSilvia MarinoPaola PolverinoUmberto AgugliaRaffaele OrnelloElisabetta PeregoGabriele SicilianoPaola MerloMarco Alfonso CapobiancoLeonardo PantoniAlessandra LugaresiStefania AngelocolaAnna De RosaMaria SessaEttore BeghiElio Clemente AgostoniSalvatore MonacoAlessandro PadovaniAlberto PrioriVincenzo SilaniGioacchino TedeschiCarlo Ferraresenull nullPublished in: Neurology (2023)
Incidence of COVID-associated neurologic disorders decreased during the pre-vaccination phase of the pandemic. Long-term functional outcome was favourable in most neuro-COVID disorders, although mild symptoms commonly lasted over 6 months after infection.